Sign In
Buy SPPI
$1.03
+0 (+0%)
At Close: Oct 30, 2023
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
07:00am, Friday, 17'th Mar 2023
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call t
How to Take Profits With Penny Stocks
06:00am, Friday, 10'th Feb 2023
Use these tips for taking profits with penny stocks The post How to Take Profits With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
10 Top Penny Stocks Under $1 To Watch For February 2023
08:28am, Thursday, 09'th Feb 2023
Penny stocks under $1 to watch this month. The post 10 Top Penny Stocks Under $1 To Watch For February 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Top Penny Stocks To Watch With Big News This Week
09:30am, Tuesday, 31'st Jan 2023
Penny Stocks With News Light Up The Scanners This Week This week
The 3 Best Biotech Stocks Under $1 to Buy for January
06:06pm, Thursday, 26'th Jan 2023
While biotech may be the next big thing, making money through it isn't easy. Indeed, investing in biotech stocks is often more of an art than a science.
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
01:32pm, Monday, 28'th Nov 2022
Spectrum (SPPI) gets a CRL from the FDA for poziotinib as the agency requires additional data. The company de-prioritized the poziotinib program.
Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2022 Earnings Call Transcript
09:40pm, Thursday, 10'th Nov 2022
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Michael Grabow - Executive Vice President of Chief Business Officer Tho
3 Hot Penny Stocks To Watch With The Stock Market Down Today
11:23am, Monday, 24'th Oct 2022
Hot penny stocks to watch with the stock market down today. The post 3 Hot Penny Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Information | P
Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug
01:32pm, Monday, 26'th Sep 2022
The FDA Oncologic Drugs Advisory Committee votes against Spectrum's (SPPI) poziotinib for treating non-small cell lung cancer in previously treated patients with HER2 exon 20 mutations. Stock down.
Spectrum's stock is down after FDA committee voted against cancer drug
08:45am, Friday, 23'rd Sep 2022
Shares of Spectrum Pharmaceuticals Inc. SPPI, -4.27% were down 22.0% in premarket trading on Friday, the day after a Food and Drug Administration committee voted 9-4 that the benefits of the company's
FDA advisory committee to review three cancer drugs this week
03:30pm, Monday, 19'th Sep 2022
A Food and Drug Administration advisory committee is set to meet this week to discuss three cancer therapies. The Oncologic Drugs Advisory Committee is set to meet Wednesday to vote whether the benefi
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
04:45pm, Monday, 12'th Sep 2022 Benzinga
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Phar
HC Wainwright & Co. Maintains Buy Rating for Spectrum Pharmaceuticals: Here's What You Need To Know
04:06pm, Monday, 12'th Sep 2022 Benzinga
HC Wainwright & Co. has decided to maintain its Buy rating of Spectrum Pharmaceuticals (NASDAQ:SPPI) and raise its price target from $10.00 to $12.00.
Shares of Spectrum Pharmaceuticals are trading up
Spectrum Pharmaceuticals (SPPI) Gets Nod for Rolvedon Injection
03:26pm, Monday, 12'th Sep 2022 Zacks Investment Research
Spectrum Pharmaceuticals (SPPI) receives FDA approval for its drug candidate, Rolvedon (eflapergrastim), for treating chemotherapy-induced neutropenia.
What Is Going on With Spectrum Pharmaceuticals (SPPI) Stock Today?
01:22pm, Monday, 12'th Sep 2022
Biotechnology firm Spectrum Pharmaceuticals (NASDAQ: SPPI ) recently received regulatory approval for its inflation-reducing injections associated with anti-cancer drugs, thus driving SPPI stock signi
